Necsoi C - Search Results

1

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.

Byonanebye DM, Polizzotto MN, Neesgaard B, Sarcletti M, Matulionyte R, Braun DL, Castagna A, de Wit S, Wit F, Fontas E, Vehreschild JJ, Vesterbacka J, Greenberg L, Hatleberg C, Garges H, Gallant J, Volny Anne A, Öllinger A, Mozer-Lisewska I, Surial B, Spagnuolo V, Necsoi C, van der Valk M, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group. Byonanebye DM, et al. Among authors: necsoi c. HIV Med. 2022 Sep;23(8):895-910. doi: 10.1111/hiv.13273. Epub 2022 Mar 1. HIV Med. 2022. PMID: 35233903 Free PMC article.

2

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients; Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, et al. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15. Lancet. 2010. PMID: 20638118 Free PMC article.

3

Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load.

De Wit S, Delforge M, Necsoi CV, Clumeck N. De Wit S, et al. AIDS. 2011 Jun 19;25(10):1332-3. doi: 10.1097/QAD.0b013e328347c083. AIDS. 2011. PMID: 21508802

4

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group. Ryom L, et al. J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4. J Infect Dis. 2013. PMID: 23382571 Free PMC article.

5

Feasibility and acceptability of HIV screening through the use of rapid tests by general practitioners in a Brussels area with a substantial African community.

Gennotte AF, Semaille P, Ellis C, Necsoi C, Abdulatif M, Chellum N, Evaldre C, Laporte F, Mernier M, Ounchif K, Gidiuta D, Schellens MJ, Clumeck N. Gennotte AF, et al. Among authors: necsoi c. HIV Med. 2013 Oct;14 Suppl 3:57-60. doi: 10.1111/hiv.12061. HIV Med. 2013. PMID: 24033907 Free article.

6

Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.

Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA; D:A:D Study Group. Worm SW, et al. BMC Infect Dis. 2013 Oct 9;13:471. doi: 10.1186/1471-2334-13-471. BMC Infect Dis. 2013. PMID: 24106926 Free PMC article.

7

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group. Kamara DA, et al. BMC Nephrol. 2014 Mar 25;15:51. doi: 10.1186/1471-2369-15-51. BMC Nephrol. 2014. PMID: 24666792 Free PMC article.

8

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.

Clumeck N, Mwamba C, Kabeya K, Matanda S, Vaira D, Necsoi C, Kadiebwe D, Delforge M, Kasamba E, Milolo C, Ilunga J, Kapend L. Clumeck N, et al. Among authors: necsoi c. AIDS. 2014 May 15;28(8):1143-53. doi: 10.1097/QAD.0000000000000214. AIDS. 2014. PMID: 25028911 Free PMC article. Clinical Trial.

9

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group. Smith CJ, et al. Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8. Lancet. 2014. PMID: 25042234 Free article.

10

Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations.

Markowicz S, Delforge M, Necsoi C, De Wit S. Markowicz S, et al. Among authors: necsoi c. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19515. doi: 10.7448/IAS.17.4.19515. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394024 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters